Table 2 Information on candidate genes and validation of somatic mutations by Sanger sequencing

From: Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling

  

Exome sequencing (sample #1)

Sanger sequencing

Gene Name

Gene Description

Allele (%)

Variant

Primary Tumor (sample #1)

Ascites (sample #4)

Pleural metastases (sample #2)

SCN1B

sodium channel, voltage-gated, type I, beta

52.4

c.218A > G:p.Y73C

218A > G

218A > G

218A > G

PPP1R3A

protein phosphatase 1, regulatory subunit 3A

46.5

c.1941T > A:p.D647E

1941T > A

1941T > A

1941T > A

GRID2

glutamate receptor, ionotropic, delta 2

46.3

c.1944C > A:p.Y648X

Fail

1944C > A

1944C > A

APBA2

amyloid beta (A4) precursor protein-binding, family A, member 2

43.4

c.266G > A:p.G89D

WT

266G > A

266G > A

ZNF142

zinc finger protein 142

42.9

c.1138G > A:p.A380T

WT

1138G > A

1138G > A

ZYG11A

zyg-11 homolog A (C. elegans)

41.9

c.1762G > T:p.E588X

1762G > T

1762G > T

1762G > T

RBFOX1

RNA binding protein, fox-1 homolog (C. elegans) 1

39.8

c.241C > A:p.H81N

WT

241C > A

241C > A

TCF7L1

transcription factor 7-like 1 (T-cell specific, HMG-box)

31.6

c.1006GA:p.V336M

WT

WT

WT

TEX13B

testis expressed 13B

22.2

c.406C > T:p.L136F

WT

WT

WT

DSCAML1

Down syndrome cell adhesion molecule like 1

13.5

c.3110T > G:p.L1037R

WT

WT

WT